skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

99+ Total results for product and free and sample content found

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Quick Listen: Scrip's Five Must-Know Things

Join us for a quick audio roundup of major events in the global biopharma industry over the past week, as reported by Scrip.

Topic Coronavirus Clinical Trials Vaccines

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Lilly's Olumiant Cuts COVID-19 Hospital Stays By One Day

Covid19 Infection

Olumiant (baricitinib) plus Gilead’s Veklury (remdesivir) provided a statistically significant reduction in time to recovery versus remdesivir alone for hospitalized patients in US NIAID’s ACTT-2 clinical trial.

Topic Coronavirus clinical-trials research

Citeline

The Future of Clinical Trials From the Investigator Perspective Webinar

The Future of Clinical Trials From the Investigator Perspective Webinar

Listen to our podcast “The Future of Clinical Trials From the Investigator Perspective” from earlier this year and register for our upcoming webinar to learn new developments

Topic Clinical Trials Coronavirus

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Pharma Stands Up To Trump Pressure With COVID-19 Vaccines Science Pledge

CEOs from the most advanced vaccines developers pledge to maintain standards – for the sake of safety, efficacy and public trust in vaccines

Topic clinical-trials

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Coronavirus Update: After Rumors Of Shortcut To Market, AZ Pledges To 'Follow Science' In Vaccine Trials

The company reiterates core values to 'follow the science' and 'put patients first' after talk of an emergency use authorization without completing Phase III trials.

Topic Coronavirus Clinical Trials Research & Development

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Coronavirus Update: End Of The Road For Kevzara In COVID-19

Covid19 kevzara

Sanofi/Regeneron are ending development of Kevzara for COVID-19 after Phase III disappointments. Meanwhile Regeneron is ramping up biologics manufacturing in Ireland as it makes way for COVID-19 antibody production in New York, and multiple vaccines move forward in Japan with new funding and trials

Topic Coronavirus clinical-trials

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Coronavirus Update: Moderna In Advanced Talks With Europe On Vaccine Supplies

The deal would include an option for expansion to 160 million doses of the mRNA-based vaccine.

Topic Coronavirus clinical-trials vaccines

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

After Blood Plasma Emergency Use Authorization, Can Takeda Develop A More Potent Alternative?

After the FDA's emergency use authorization for convalescent plasma, pushed on by President Trump, an alliance of firms is working with the NIH to conduct a robust study of a potentially more potent alternative.

Topic Coronavirus Clinical Trials

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。